Stock Screener Based on Stock Prediction Algorithm: Returns up to 16.33% in 3 Days

Stock Screener

An insider is legally permitted to buy and sell shares of the firm – and any subsidiaries – that employs him or her. However, these transactions must be properly registered with the Securities and Exchange Commission (SEC) and are done with advance filings. You can find details of this type of insider trading on the SEC’s EDGAR database. This algorithmic forecast is for stocks with recently reported insiders’ transactions.An “insider” is any person who possesses at least one of the following:

  • access to valuable non-public information about a corporation (for example a company’s directors and high-level executives)
  • ownership of more than 10% of the company’s equity

insider trading
Package Name: Insiders Stocks
Recommended Positions: Long
Forecast Length: 3 Days (12/25/2018 – 12/28/2018)
I Know First Average: 6.90%
Stock Screener

The algorithm correctly predicted 10 out 10 of the suggested trades in the Insiders Stocks Package for this 3 Days forecast. ELGX was the highest-earning trade with a return of 16.33% in 3 Days. Additional high returns came from SGMS and SYBT, at 11.69% and 7.72% respectively. The package had an overall average return of 6.90%, providing investors with a 1.17% premium over the S&P 500’s return of 5.73% during the period.

Endologix, Inc., incorporated on June 2, 1993, is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Sales of the Company’s EVAR and EVAS platforms (including extensions and accessories) to hospitals in the United States and Europe, and to third-party international distributors provide the sole source of its revenue. It offers various accessories to facilitate the optimal delivery of its EVAR and EVAS products, including compatible guidewires, snares, and catheter introducer sheaths.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.